A COMPARISON OF AXONAL AND SOMATODENDRITIC DOPAMINE RELEASE USING INVIVO DIALYSIS

被引:155
作者
KALIVAS, PW
DUFFY, P
机构
[1] Department of Veterinary and Comparative Anatomy, Pharmacology, and Physiology, Washington State University, Pullman, Washington
关键词
DOPAMINE; NUCLEUS ACCUMBENS; A10-REGION; RELEASE; TTX; AMPHETAMINE;
D O I
10.1111/j.1471-4159.1991.tb02015.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The release of endogenous dopamine from the axon terminal field in the nucleus accumbens and from the A10 dopamine cell bodies of conscious rats was measured using intracranial dialysis. Release of dopamine from both areas was calcium-dependent and markedly inhibited by the presence of the D2 agonist, quinpirole, in the dialysis buffer. However, the addition of tetrodotoxin to the buffer produced less of a decrease in dopamine in the A10 region than in the nucleus accumbens. When dopamine release was examined by substituting K+ for Na+ or by adding amphetamine to the buffer, the evoked release was significantly less in the A10 region than in the nucleus accumbens. Likewise, enhanced extracellular dopamine following blockade of reuptake by nomifensine addition to the dialysis buffer was not as great in the A10 region as in the nucleus accumbens. These data argue that, in general, axonal and somatodendritic dopamine release are regulated by similar factors, although somatodendritic release is less influenced by action potential generation and less responsive to some releasing agents.
引用
收藏
页码:961 / 967
页数:7
相关论文
共 57 条
[1]   EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].
ANDEN, NE ;
RUBENSON, A ;
FUXE, K ;
HOKFELT, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&
[2]  
[Anonymous], 1979, STEREOTAXIC ATLAS RA
[3]   INFLUENCE OF MONOAMINE-OXIDASE INHIBITION ON THE RELEASE OF H-3-DOPAMINE ELICITED BY POTASSIUM AND BY AMPHETAMINE FROM THE RAT SUBSTANTIA NIGRA AND CORPUS STRIATUM [J].
ARBILLA, S ;
LANGER, SZ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 311 (01) :45-52
[4]   EFFECT OF DOPAMINE AGONISTS AND ANTAGONISTS ON DOPA FORMATION IN THE SUBSTANTIA NIGRA [J].
ARGIOLAS, A ;
MELIS, MR ;
FADDA, F ;
SERRA, G ;
GESSA, GL .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (01) :75-79
[5]  
BAYER VE, 1989, SOC NEUR ABSTR, V15
[6]   NEUROCHEMICAL STUDIES OF THE MESOLIMBIC DOPAMINERGIC PATHWAY - SOMATODENDRITIC MECHANISMS AND GABAERGIC NEURONS IN THE RAT VENTRAL TEGMENTUM [J].
BEART, PM ;
MCDONALD, D .
JOURNAL OF NEUROCHEMISTRY, 1980, 34 (06) :1622-1629
[7]   MESOLIMBIC DOPAMINERGIC-NEURONS AND SOMATO-DENDRITIC MECHANISMS [J].
BEART, PM ;
MCDONALD, D ;
GUNDLACH, AL .
NEUROSCIENCE LETTERS, 1979, 15 (2-3) :165-170
[8]   DOPAMINE IN DENDRITES OF SUBSTANTIA NIGRA NEURONS - SUGGESTIONS FOR A ROLE IN DENDRITIC TERMINALS [J].
BJORKLUND, A ;
LINDVALL, O .
BRAIN RESEARCH, 1975, 83 (03) :531-537
[9]   COCAINE INCREASES EXTRACELLULAR DOPAMINE IN RAT NUCLEUS ACCUMBENS AND VENTRAL TEGMENTAL AREA AS SHOWN BY INVIVO MICRODIALYSIS [J].
BRADBERRY, CW ;
ROTH, RH .
NEUROSCIENCE LETTERS, 1989, 103 (01) :97-102
[10]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V23, P1715